Delivery Order SPE2DR25D1100-SPE2DR26FCU8F
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,616.18 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on December 4, 2025, with completion scheduled for December 5, 2025. This competitive, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NURTEC ODT is a prescription migraine treatment medication, reflecting the pharmaceutical supply...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $9,973.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on September 15, 2025, with an ultimate completion date of September 16, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,948.56 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on August 13, 2025, with an ultimate completion date of August 14, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for acute migraine treatment,...
- The Defense Logistics Agency awarded a $2,281.03 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count package) on December 16, 2025, with completion targeted for December 17, 2025. This non-competitive, firm fixed-price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in...
- The Defense Logistics Agency awarded a delivery order valued at $11,877.47 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count packaging) on December 5, 2025, with an ultimate completion date of December 8, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. NURTEC ODT is a migraine treatment medication, consistent with AmerisourceBergen's role as a major...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $18,159.04 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 3, 2025, with an ultimate completion date of December 4, 2025. This is a firm fixed-price, non-competitive delivery order executed under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical prime vendor agreement valued at $999.9 billion and...
- The Defense Logistics Agency awarded a delivery order valued at $20,526.67 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count units) on December 3, 2025, with a completion date of December 4, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, reflecting the pharmaceutical supplier's role in supporting...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $23,214.37 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8 count) on September 22, 2025, with an ultimate completion date of September 23, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child order under AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order valued at $5,213.34 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-unit package) on November 12, 2025, with an ultimate completion date of November 13, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a migraine treatment medication, representing one component of the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,868.57 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8 count) on October 23, 2025, with completion expected by October 24, 2025. This firm fixed price delivery order was awarded competitively without a set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for acute migraine treatment, representing one...
- SPE2DR25D1100Indefinite Delivery Contract
- SPE2DR25D1100-SPE2DR26FCU8FDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $10,382.44 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units) on December 15, 2025, with completion scheduled for December 16, 2025. This firm fixed-price delivery order represents a non-competitive award issued under an existing contract vehicle and will be performed at the contractor's facility in Conshohocken, Pennsylvania. NURTEC ODT is a prescription medication used for migraine treatment, reflecting the pharmaceutical and medical supply distribution services that AmerisourceBergen provides to federal healthcare systems. This delivery order is issued under AmerisourceBergen Drug Corp's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen supplies a comprehensive range of medications, vaccines, and medical devices to support military and veteran healthcare systems worldwide. The company's extensive federal contract portfolio demonstrates its capability to fulfill competitive federal procurement requirements across multiple therapeutic domains and customer bases, including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $10.4k | 12/14/25 |